What is Rawsome?
Rawsome is a Texas-based company specializing in a diverse range of CBD products, including tinctures, gummies, balms, and roll-ons. Their offerings are crafted with organic ingredients and are available in various strengths and sizes, catering to individual needs for natural relief from anxiety, joint pain, and skin issues. The company emphasizes the therapeutic potential of cannabidiol and is committed to providing excellent customer service.
How much funding has Rawsome raised?
Rawsome has raised a total of $323K across 2 funding rounds:
Debt
$150K
Debt
$173K
Debt (2020): $150K with participation from PPP
Debt (2021): $173K led by PPP
Key Investors in Rawsome
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Rawsome?
With its recent strategic investment, Rawsome is poised for accelerated expansion and product development. The substantial capital injection, particularly the $173K received in March 2021, suggests a focus on scaling operations, enhancing market reach, and potentially innovating new product lines. This late-stage funding context indicates Rawsome is likely moving towards broader market penetration and solidifying its position as a key player in the natural wellness sector. Future strategic moves may involve expanding distribution channels and further research into the efficacy of their CBD formulations.
See full Rawsome company page
